However, these medications are not FDA-approved, so buyer beware. The competing GLP-1 drug tirzepatide (Mounjaro, Zepbound) is similarly branded by a single company, Cutler continued
Ako imate zdravstveno stanje ili uzimate propisane lijekove, posavjetujte se sa zdravstvenim djelatnikom prije poetka
These numbers are unusually strong for a nonrandomized oncology-adjacent study, which is exactly why they are both intriguing and difficult to accept at face value
Esta nova abordagem, combina uma avaliao clnica especializada com um tratamento inovador base de agonistas GLP-1, promovendo uma perda de peso segura, eficaz e sustentvel
Some patients start with semaglutide and switch to tirzepatide if they plateau
*Correspondence: Jing-Dong Xu, [email protected] This article was submitted to Gut Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
